衰弱与无冠心病老年人的心血管结局:NHATS研究
基于美国国家健康与老龄化趋势研究(NHATS)的前瞻性队列,纳入基线无冠心病史的老年人,采用Fried衰弱表型评估衰弱,随访6年。结果显示,衰弱者全因死亡及各项心血管结局(MACE、死亡、心梗、卒中、外周血管病、冠心病)风险均显著高于非衰弱者。
要点
- 在无冠心病史的老年人中,衰弱与6年内MACE风险独立相关(HR 1.77)。
- 衰弱者全因死亡风险是非衰弱者的2.70倍,心梗、卒中、外周血管病风险也显著升高。
- 识别并干预衰弱可能有助于减少后续不良心血管事件。
核心结论
- 在基线无冠心病史的老年人中,衰弱是MACE发生的危险因素。
研究设计与样本
- 前瞻性队列研究,使用NHATS数据并与Medicare样本链接,排除有冠心病史者,基线采用Fried衰弱表型评估衰弱,随访6年。
- 4656名参与者中,3259名(70%)在基线访视前1年无冠心病史。
主要发现
- 与非衰弱者相比,衰弱者年龄更大(平均82.1岁 vs 75.1岁,P < 0.001),女性比例更高(68.3% vs 54.9%,P < 0.001),且少数族裔比例更高。
- 衰弱和衰弱前期患者的高血压、跌倒、残疾、焦虑/抑郁及多病共存患病率均显著高于非衰弱者。
- Cox多变量模型显示,6年随访期间衰弱者MACE风险显著升高(HR 1.77,95%CI 1.53-2.06)。
- 衰弱者死亡风险(HR 2.70,95%CI 2.16-3.38)、急性心肌梗死(HR 1.95,95%CI 1.31-2.90)、卒中(HR 1.71,95%CI 1.34-2.17)、外周血管病(HR 1.80,95%CI 1.44-2.27)及冠心病(HR 1.35,95%CI 1.11-1.65)风险均显著升高。
临床怎么用
- 在无冠心病史的老年患者中,应识别衰弱状态,因其与MACE及全因死亡风险升高相关。
- 针对衰弱的干预措施可能有助于减少后续不良心血管事件。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Physical frailty is a commonly encountered geriatric syndrome among older adults without coronary heart disease (CHD). The impact of frailty on the incidence of long-term cardiovascular outcomes is not known.We aimed to evaluate the long-term association of frailty, measured by the Fried frailty phenotype, with all-cause-mortality and MACE among older adults without a history of CHD at baseline in the National Health and Aging Trends Study. METHODS AND RESULTS: We used the National Health and Aging Trends Study, a prospective cohort study linked to a Medicare sample. Participants with a prior history of CHD were excluded. Frailty was measured during the baseline visit using the Fried physical frailty phenotype. Cardiovascular outcomes were assessed during a 6-year follow-up.Of the 4656 study participants, 3259 (70%) had no history of CHD 1 year prior to their baseline visit. Compared to those without frailty, subjects with frailty were older (mean age 82.1 vs. 75.1 years, P < 0.001), more likely to be female (68.3% vs. 54.9%, P < 0.001), and belong to an ethnic minority. The prevalence of hypertension, falls, disability, anxiety/depression, and multimorbidity was much higher in the frail and pre-frail than the non-frail participants. In a Cox time-to-event multivariable model and during 6-year follow-up, the incidences of death and of each individual cardiovascular outcomes were all significantly higher in the frail than in the non-frail patients including major adverse cardiovascular event (MACE) [hazard ratio (HR) 1.77, 95% confidence interval (CI) 1.53, 2.06], death (HR 2.70, 95% CI 2.16, 3.38), acute myocardial infarction (HR 1.95, 95% CI 1.31, 2.90), stroke (HR 1.71, 95% CI 1.34, 2.17), peripheral vascular disease (HR 1.80, 95% CI 1.44, 2.27), and coronary artery disease (HR 1.35, 95% CI 1.11, 1.65). CONCLUSION: In patients without CHD, frailty is a risk factor for the development of MACEs. Efforts to identify frailty in patients without CHD and interventions to limit or reverse frailty status are needed and, if successful, may limit subsequent adverse cardiovascular events.
引用
- Damluji AA, Chung SE, Xue QL, et al. Frailty and cardiovascular outcomes in the National Health and Aging Trends Study. Eur Heart J. 2021. PMID: 34324648. doi:10.1093/eurheartj/ehab468
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。